Allergan plc (AGN) [Rocket]

In millions, except per share items	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13	Dec-31-12
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
Corporate	32.0	39.5	21.4
Anda Distribution							1,561.1	986.4
Other	16,056.9	15,747.9	15,919.3				1,041.4	4,928.5
Total revenues	16,088.9	15,787.4	15,940.7	33,396.4	12,688.1	4,676.5	2,602.5	5,914.9
Revenue growth [+]	1.9%	-1.0%	-52.3%	163.2%	171.3%	79.7%	-56.0%	29.0%
Corporate	-19.0%	84.6%
Anda Distribution							58.3%	27.1%
Cost of goods sold	4,686.3	4,186.3	4,060.8	3,969.5	5,004.1	3,262.7	2,531.9	4,219.6
Gross profit	11,402.6	11,601.1	11,879.9	29,426.9	7,684.0	1,413.8	70.6	1,695.3
Gross margin	70.9%	73.5%	74.5%	88.1%	60.6%	30.2%	2.7%	28.7%
Selling, general and administrative [+]	6,096.0	4,697.0	5,281.8	5,061.3	4,753.1	2,499.2	1,118.6	1,340.0
Sales and marketing	3,461.7	3,250.6	3,514.8	3,266.4	2,765.1	1,066.0	374.8	546.5
General and administrative	2,634.3	1,446.4	1,767.0	1,473.9	1,716.4	1,201.4	456.1	625.3
Other selling, general and administrative				321.0	271.6	231.8	287.7	168.2
Research and development	1,812.0	2,266.2	2,100.1	2,575.7	2,358.5	605.7	191.3	402.5
Other operating expenses	3,510.9	4,382.2	6,491.5	22,866.5	2,919.8	146.1	-871.1	-512.4
EBITDA [+]	6,044.8	7,004.3	5,375.1	5,554.4	3,647.9	991.2	676.5	1,043.8
EBITDA growth	-13.7%	30.3%	-3.2%	52.3%	268.0%	46.5%	-35.2%	7.5%
EBITDA margin	37.6%	44.4%	33.7%	16.6%	28.8%	21.2%	26.0%	17.6%
Depreciation	204.5	196.3	171.5	155.8	218.3	230.9	202.0	97.5
EBITA	5,840.3	6,808.0	5,203.6	5,398.6	3,429.6	760.3	474.5	946.3
EBITA margin	36.3%	43.1%	32.6%	16.2%	27.0%	16.3%	18.2%	16.0%
Amortization of intangibles	5,856.6	6,552.3	7,197.1	6,475.2	5,777.0	2,597.5	842.7	481.1
EBIT [+]	-16.3	255.7	-1,993.5	-1,076.6	-2,347.4	-1,837.2	-368.2	465.2
EBIT growth	-106.4%	-112.8%	85.2%	-54.1%	27.8%	399.0%	-179.1%	-11.1%
EBIT margin	-0.1%	1.6%	-12.5%	-3.2%	-18.5%	-39.3%	-14.1%	7.9%
Non-recurring items [+]	4,429.0	6,503.3	3,927.7	748.9	783.6	730.0	1.0	149.5
Asset impairment	4,429.0	6,503.3	3,927.7	748.9	783.6	730.0	1.0	101.0
Loss (gain) on sale of assets								48.5
Interest expense, net [+]	706.2	866.0	1,027.9	1,225.7	1,182.7	403.7	235.0	109.1
Interest expense	783.0	911.2	1,095.6	1,295.6	1,193.3	411.8	239.8	111.6
Interest income	76.8	45.2	67.7	69.9	10.6	8.1	4.8	2.5
Other income (expense), net	32.8	256.7	-3,437.3	219.2	-233.8	-27.3	-18.6	38.5
Pre-tax income	-5,118.7	-6,856.9	-10,386.4	-2,832.0	-4,547.5	-2,998.2	-622.8	245.1
Income taxes	146.4	-1,770.7	-6,670.4	-1,897.0	-1,605.9	-513.6	-155.3	146.8
Tax rate		25.8%	64.2%	67.0%	35.3%	17.1%	24.9%	59.9%
Minority interest	5.9	10.2	6.6	6.1	4.2			1.0
Earnings from continuing ops	-5,271.0	-5,142.8	-4,001.0	-1,219.5	-3,177.8	-2,484.6	-467.5	97.3
Earnings from discontinued ops			-402.9	15,914.5	6,861.0	854.1	-282.9
Net income	-5,271.0	-5,142.8	-4,403.9	14,695.0	3,683.2	-1,630.5	-750.4	97.3
Net margin	-32.8%	-32.6%	-27.6%	44.0%	29.0%	-34.9%	-28.8%	1.6%

Basic EPS [+]	($16.02)	($15.26)	($11.99)	($3.17)	($8.64)	($11.31)	($3.29)	$0.77
Growth	5.0%	27.3%	278.3%	-63.3%	-23.6%	244.2%	-524.8%	-63.1%
Diluted EPS [+]	($16.02)	($15.26)	($11.99)	($3.17)	($8.64)	($11.31)	($3.29)	$0.76
Growth	5.0%	27.3%	278.3%	-63.3%	-23.6%	244.2%	-533.5%	-63.3%

Dividends per share [+]	$2.96	$3.12	$3.65	$0.72	$0.57
Growth	-4.9%	-14.6%	404.6%	27.8%

Shares outstanding (basic) [+]	329.0	337.0	333.8	384.9	367.8	219.7	142.3	125.8
Growth	-2.4%	1.0%	-13.3%	4.6%	67.4%	54.4%	13.1%	1.0%
Shares outstanding (diluted) [+]	329.0	337.0	333.8	384.9	367.8	219.7	142.3	128.4
Growth	-2.4%	1.0%	-13.3%	4.6%	67.4%	54.4%	10.8%	1.5%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.